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DNA replication is performed by a
multiprotein complex known as the
‘replisome,’which is assembled and reg-
ulated in a cell cycle–dependent manner.
Hypomorphic mutations of components
of the replisome lead to defective devel-
opment, reduced growth, and altered
tissue homeostasis.
Whole-genome sequencing studies sig-
nificantly expanded the repertoire of
mendelian diseases caused by mutation
of the replication machinery.Human development and tissue homeostasis depend on the regulated control of
cellular proliferation and differentiation. DNA replication is essential to couple
genome duplication and cell division with the establishment and maintenance
of cellular differentiation programs. In eukaryotes, DNA replication is performed
by a large machine known as the ‘replisome,’ which is strictly regulated in a cell
cycle-dependent manner. Inherited mutations of replisome components have
been identified in a range of genetic conditions characterised by developmental
abnormalities and reduced organismal growth in addition to an involvement of
the immune and endocrine systems and/or heightened tumour predisposition.
Here, we review the current knowledge of the molecular genetics of replisome
dysfunction disorders and discuss recent mechanistic insights into their patho-
genesis, with a focus on the specific steps of DNA replication affected in these
human diseases.Phenotypic analysis and mechanistic
studies support defective replication origin
assembly and activation and perturbation
of replication fork stability as the pathoge-
netic mechanisms of replication-linked
human genetic diseases.
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Efficient and accurate DNA replication is essential for the maintenance of genome stability and the
accomplishment of developmental and differentiation programs in mammals. In vivo and in vitro
studies in budding yeast and other lower eukaryotes have provided a clear understanding of
the key steps involved in the control and execution of DNA replication [1]. Although redundancy
has emerged during the evolution of higher eukaryotes, the basic mechanisms and players that
perform DNA replication appear to be remarkably conserved. Over the last two decades, many
of the basic components of the mammalian DNA replication machinery have been identified
and functionally characterised. Proteomic studies have also identified several mammalian-
specific factors stably or transiently associated with the replisome (see Glossary), particularly
in the presence of replication stress, with a prominent role in maintaining genome stability
and human health [2,3].
Even though the vast majority of replisome factors are required for viability of mammalian cells,
hypomorphic mutations of replisome components have been increasingly identified in human
genetic disease. Indeed, the application of whole-genome sequencing has led to a significant
expansion in the identification of mutations in components of the replication machinery and
factors required to maintain replication fork stability. While leading to a deeper understanding
of the molecular genetics of these conditions, this has promoted new opportunities to investigate
the pathological consequences of dysfunctional DNA replication in human biology and disease.
The Mechanism of DNA Replication in Mammalian Cells
Duplication of genomic DNA is performed by a large multiprotein assembly, known as the
‘replisome,’whose activation and activity are strictly regulated during the cell cycle by a multistep
process (Figure 1 and Box 1). The first step of DNA replication takes place during the G1 phase of
the cell cycle, when DNA replication origins are ‘licensed’ by the sequential assembly of origin
recognition complex 1–6 (ORC1–6) together with cell division cycle 6 (CDC6) and Cdc10-Trends in Genetics, Month 2020, Vol. xx, No. xx https://doi.org/10.1016/j.tig.2020.09.008 1
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Glossary
Adrenal insufficiency: reduced
function of the adrenal gland that leads
to impaired secretion of cortisol and/or
aldosterone. It can be caused by
genetic, immunologic, or infiltrative/
haemorrhagic insults.
Consanguineous: genetically
descendent from the same ancestor as
another person.
DNA–protein crosslinks (DPCs):
covalent linkage of proteins with a DNA
strand. DPCs are one of the most
deleterious forms of DNA damage
because they constitute an allosteric
block to transcription and replication.
They can be induced endogenously
(commonly through reactions with
aldehydes or trapping of enzymatic
intermediates onto the DNA) or through
environmental carcinogens and
chemotherapeutic agents.
DNA replication origins: specific
genetic sequences where DNA
replication is initiated.
Fork reversal: conversion of the classic
three-way replication fork into a four-way
junction (also known as ‘chicken foot
structure’) due to reannealing of
unwound parental duplex and annealing
of the ones with strands.
Hypomorphic allele: Mutant allele that
causes a partial loss of gene function. It
is generally caused by reduced
expression (at the mRNA and/or protein
levels) or functional activity of the codified
mutant protein.
Hypoplasia: congenital condition
associated with underdevelopment of a
specific tissue or organ. It is caused by a
reduced and/or inadequate number of
cells.
Interstrand crosslinks (ICLs): DNA
lesions generated by the covalent
linkage between the Watson and Crick
DNA strands. ICLs are highly toxic
because they prevent strand separation,
thus blocking DNA replication and
transcription.
Intra-S-phase checkpoint:
mechanism that controls genomic
replication to be performed accurately
and effectively during the S phase of the
cell cycle.
Male hypogonadism: condition that
results from the failure to produce
physiological concentrations of
testosterone, normal amounts of sperm,
or both. It may arise from testicular
disease (primary hypogonadism) or
dysfunction of the hypothalamic–
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Figure 1. Licensing and Activation of a Human DNA Replication Origin. Cartoon depicting the three main steps
required for initiation of DNA replication at a replication origin. Formation of the pre-replication complex (PRE-RC): The
origin recognition complex 1–6 (ORC1–6) initially recruits cell division cycle 6 (CDC6) at replication origins to form an AAA+
ring-shaped complex that encircles DNA and promotes the subsequent recruitment of mini-chromosome maintenance
2–7 (MCM2–7)/Cdc10-dependent transcript 1 (CDT1) and loading of MCM2–7 double hexamers at a replication origin
(Figure legend continued at the bottom of the next page.
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pituitary unit (secondary hypogonadism
or hypogonadotropic hypogonadism).
Mendelian disorders: disorders that
result from a mutation at a single genetic
locus in an autosome or sex
chromosome. They might present in a
dominant or recessive mode of
inheritance.
Microcephaly: genetic or acquired
condition in which the head of the
newborn is smaller than normal, as
diagnosed by measurement of the
occipitofrontal circumference. It is
caused by congenital insufficiency
during foetal brain development, and its
extent generally correlates with the
severity of mental retardation.
Origin licensing: first step required for
DNA replication. It involves loading of the
replicative helicase at replication origins
by components of the pre-replication
complex.
Primary immunodeficiency: genetic
disorder of the immune system,
generally resulting in development of
recurrent and/or more severe infections.
Primordial dwarfism: group of genetic
disorders characterised by prenatal and
postnatal growth retardation. This
results in individuals extremely small
(dwarfs) for their age even as a foetus.
Pulmonary emphysema: abnormal
and permanent enlargement of
airspaces distal to terminal bronchioles
associatedwith alveolar wall destruction.
Replication fork: DNA structure
generated when dsDNA unwinding by
the replicative helicase is coupled to
synthesis of the complementary strands.
Replication fork collapse: failure to
stabilise a stalled replication fork that
results in its inability to resume DNA
synthesis and processing into a double-
strand break.
Replication stress: alteration of the
dynamics of DNA replication associated
with fork stalling and slowing,
accumulation of ssDNA at the replication
fork, and activation of the intra-S-phase
Box 1. Mechanisms of Control of Origin Licensing and Activation
Sophisticated mechanisms have evolved to control the major steps of DNA replication, from PRE-RC complex formation
and replication origin activation to replisome activity and replication fork stability. Defects in any one of these mechanisms
can significantly impact genome stability and human development and are associated with congenital human disease.
Regulation of licensing of DNA replication origins is particularly crucial for the maintenance of genome integrity. Accordingly,
loading of MCM2–7 on chromatin is limited to the G1 phase of the cell cycle by several mechanisms that control overall levels
and/or localisation of the licensing factors ORC1–6, CDC6, and CDT1 [110].
Early studies in budding yeast defined two separate phases of the cell cycle, characterised by low or high CDK activity
associated with licensing or activation of DNA replication origins in a mutually exclusive manner. CDK activity, while
promoting activation of DNA replication origins, restrains PRE-RC complex formation and origin re-licensing through
inhibitory phosphorylation [111]. In mammalian cells, several CDK-independent mechanisms have also emerged, targeting
the licensing factor CDT1 [110]. Thus, in addition to CDK-dependent phosphorylation and SKP2-mediated ubiquitylation/
degradation, the CRL4-CDT2 ubiquitin ligase targets CDT1 for replication-coupled destruction in a PCNA-dependent
manner [112]. Furthermore, CDT1 association with the S phase–specific inhibitor, GEMININ, inhibits PRE-RC assembly
by sequestering CDT1 in an inactive complex that is unable to interact with or recruit MCM2–7 [69,70] (Figure 1).
Importantly, during the G1 phase an excess of MCM2–7 double hexamers are loaded onto genomic DNA. Known as the
MCM paradox, this phenomenon has been associated with the presence of accessory or ‘dormant’ replication origins.
Dormant origins can be activated under conditions of replicative stress [113,114] in order to rescue replication fork stalling
and facilitate completion of genome-wide replication.
Initiation of DNA replication, upon DDK and CDK activation, takes place at thousands of genomic sites in a strictly regulated
manner [115]. Although specific sequence and chromatin features recently emerged as regulators of replication origin activity,
in metazoans, flexibility in origin usage couples DNA replication and genome structure and function (e.g., transcriptional
programs) [115]. In addition to this, a series of chromatin marks, including histone acetylation and methylation, have been
associated with PRE-RC activity and/or origin activation [115]. Finally, replication origins are activated in a temporally
regulated manner to prevent exhaustion of replication factors and dNTPs and allow accurate and complete DNA replication
before transition into G2/M phase [115].
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OPEN ACCESSdependent transcript 1 (CDT1), which promote loading of inactive mini-chromosome mainte-
nance 2–7 (MCM2–7) double hexamers at DNA replication origins [4] (Figure 1). Historically, the
factors required for licensing of replication origins are also known as components of the pre-rep-
lication complex (PRE-RC) [1].
At the G1–S transition, a series of Dbf4-dependent kinase (DDK) and cyclin-dependent kinase
(CDK) phosphorylation events drive assembly of the eukaryotic processive helicase CMG,
which comprises CDC45, MCM2–7, and the Go-Ichi-Ni-San (GINS) complex (composed of
PSF1, PSF2, PSF3, and SLD5; also known as ‘GINS1–4’ in mammals [5]). While MCMs repre-
sent the key targets of DDK activity, CDKs phosphorylate the essential pre-initiation factors
TopBP1-interacting checkpoint and replication regulator (TICRR)/TRESLIN and RECQ-like
helicase 4 (RECQL4; Sld3 and Sld2 in budding yeast), allowing BRCT-dependent binding to
DNA topoisomerase II–binding protein 1 (TOPBP1; Dpb11 in Saccharomyces cerevisiae) and
recruitment of CDC45 and GINS1–4 in concert with DNA polymerase epsilon (Pol ε) [6–checkpoint.
Replisome: large machinery that
carries out DNA replication during the S
phase of the cell cycle. It consists of a
helicase complex that unwinds dsDNA
in conjunction with DNA polymerases
that copy it and a series of nucleases
and ligases that process lagging
strands.
Stalled replication forks: replication
forks that have prematurely stopped
synthesizing DNA.
Syndactyly: congenital defect in which
two or more digits are fused together. It
This involves the formation of a transient intermediate known as ‘OCCM’ (ORC-CDC6-CDT1-MCM) [4]. Licensing o
replication origins is restricted to the G1 phase by several mechanisms, which include the vertebrate-specific facto
GEMININ, which binds to CDT1 during the S and G2 phases of the cell cycle to prevent its interaction with MCMs [69,70]
Formation of the pre-initiation complex (PRE-IC): Dbf4-dependent kinase (DDK) initially phosphorylates MCMs and
promotes binding of TopBP1-interacting checkpoint and replication regulator (TICRR)/TRESLIN and CDC45 to replication
origins [1]. Subsequently, cyclin-dependent kinases (CDKs) phosphorylate TICRR/TRESLIN and RECQ-like helicase 4
(RECQL4) and induce binding to TOPBP1 and recruitment of Go-Ichi-Ni-San (GINS) complex (GINS1–4) in concert with
POLε [6–10]. Origin activation (or firing): Recruitment of MCM10 leads to activation of the CMG (CDC45/MCM2-7/GINS1-
4) helicase, thus promoting double-stranded DNA (dsDNA) melting and single-stranded DNA (ssDNA) extrusion from the
MCM2–5 gate [12]. dsDNA unwinding by the CMG causes the formation of ssDNA, which is rapidly coated by replication
protein A (RPA), leading to the formation of two symmetric replication forks that travel in opposite directions [13].
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might be genetically inherited, isolated in
the context of a specific syndrome, or
caused by exposure to environmental
factors during pregnancy.
Whole-exome sequencing (WES):
high-throughput technique for
sequencing of all the protein-coding
regions (or the exome) of a specific
genome.
Trends in Genetics10]. In addition to this, MDM two binding protein (MTBP; the ortholog of S. cerevisiae Sld7)
interacts with TICRR/TRESLIN to promote CDC45 binding to MCMs and CMG assembly
[11]. All together, these proteins form the so-called pre-initiation complex (PRE-IC) [1]
(Figure 1).
PRE-IC engagement with MCM10 triggers double-stranded DNA (dsDNA) melting and
unwinding by the CMG. Replication protein A (RPA) is recruited to the resulting single-
stranded DNA (ssDNA), and two separate replisomes are established, which translocate
along ssDNA in a 3′–5′ direction [12,13] (Figure 1). After POLα-dependent synthesis
of short RNA-DNA primers, leading and lagging strands are extended by the conserved
polymerases POLε and POLδ [14] (Figure 2). In vitro reconstitution of DNA replication, as
well as genetic and proteomic evidence in vivo have established that, in unchallenged con-
ditions, POLε synthesises the majority of leading strand whereas POLδ is responsible for lag-
ging strand extension [14]. Importantly, while POLδ is indirectly tethered to the replication
fork, POLα appears to be physically coupled to the CMG by the AND-1/CTF4 trimer, a
‘hub’ that links multiple CTF4-interacting peptide (CIP) box–containing proteins to the
CMG helicase [15] (Figure 2).
Other essential components of the replication machinery are the replication factors C1–5
(RFC1–5) and chromosome transmission fidelity 18 (CTF18)–RFC2–5 complexes (or clamp
loaders), which promote loading of the processive polymerase factor proliferating cell nuclear
antigen (PCNA), a trimeric scaffold that encircles ssDNA–dsDNA junctions and promotes efficient
synthesis on lagging and leading strands [14] (Figure 2). Upon extension of lagging-strand
synthesis by POLδ, 5′ flap structures are generated that are processed by flap structure–specific
endonuclease 1 (FEN1) or DNA replication helicase/nuclease 2 (DNA2; long flaps) before ligase
1–mediated ligation of end products [14] (Figure 2). In addition to this, CLASPIN (Mrc1 in
S. cerevisiae) and the TIPIN/TIMELESS heterodimer (homologues of Csm3/Tof1) engage with
the replisome to promote efficient DNA replication in unperturbed and perturbed conditions [1]
(Figure 2). Finally, termination of DNA replication occurs stochastically in the genome upon repli-
cation fork convergence, which triggers ubiquitylation-dependent CMG disassembly and ligation
of end products (Box 2).Trends in Genetics
Figure 2. Structure of a Replication
Fork and Lagging-Strand DNA
Synthesis. Representative cartoon
of the main components of the
mammalian replisome. The CMG
helicase, in concert with POLε, forms
the core of the unwinding machine
[14]. The TIM–TIPIN complex sits
ahead of the replication fork and grips
double-stranded DNA [101]. CLASPIN/
MRC1 interact with several components
of the replisomes, including TIPIN,
MCMs, AND-1/CTF4, and POLε [101].
POLα is indirectly tethered to the CMG
by the interaction with AND-1/CTF4, a
trimeric complex that links the CMG to
other components of the replication
machinery endowed with a CTF4-interacting peptide (CIP) domain [15]. POLε stably interacts with the CMG via its POLE1 and
POLE2 subunits and synthesises the leading strand in a continuous manner. POLα synthesises RNA-DNA primers at the lagging
strand subsequently extended by POLδ. FEN1 and/or DNA2 cut the 5′ flaps generated by discontinuous lagging-strand
replication, which are finally ligated by ligase I [14].
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Box 2. Termination of DNA Replication
Assembly of the CMG helicase and initiation of DNA replication have been studied extensively. However, less is known
about the mechanisms that regulate convergence of replication forks and CMG disassembly at termination and the
consequence of their deregulation [1]. The CMG helicase cannot be reloaded during S phase and appears to be remark-
ably stable even in conditions of replication stress [1]. Thus, its disassembly upon fork convergence must be regulated
in a specific manner. Initial insights into this process came from the discovery of a dedicated ubiquitylation-dependent
mechanism requiring the SCFDia2 ubiquitin ligase in budding yeast and Cdc48/p97 AAA+ ATPase in S. cerevisiae
and Xenopus laevis, driving the disassembly of CMG helicase through ubiquitylation of its MCM7 subunit [116,117].
Subsequent studies identified CUL-2LRR-1 as the higher eukaryotic mediator of CMG ubiquitylation in conjunction with
the CDC-48 cofactors UFD-1 and NPL-4, which are required for its disassembly [118–120]. Importantly, CMG unloading
at termination sites occurs after the formation of fully ligated DNA products during in vitro replication in X. laevis egg
extracts, which suggested that a specific conformational change must occur to promote MCM7 ubiquitylation and p97-
dependent unfolding and disassembly of the CMG [121]. Consistent with this, in vitro reconstitution with purified
budding yeast proteins recently showed that MCM7 ubiquitylation is normally repressed throughout fork elongation by
the Y-shaped DNA structure of the replication fork itself, which is removed upon fork convergence and end-product
ligation [122]. Efficient fork convergence and termination also necessitate activity of topoisomerase II and the Pif1 and
Rrm3 DNA helicases [123]. In addition to CUL2LLR1, a mitotic backup pathway has recently been discovered that involves
the ubiquitin ligase TRAIP [124,125], which is also required for replisome disassembly at converged replication forks during
interstrand crosslink repair in X. laevis egg extracts [95] and to allow mitotic DNA synthesis (MiDAS) and rescue of under-
replicated DNA in mammalian cells [98]. All together, these studies point to an essential role for regulated CMG disassem-
bly in genome stability and human health; yet, the consequences of its dysfunction are just starting to be unveiled.
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Meier-Gorlin Syndrome
Perturbation of the dynamics of DNA replication and the cell cycle is associated with a plethora of
mendelian disorders, including microcephalic primordial dwarfisms (MPDs), characterised by a
core phenotype of pre- and postnatal growth restriction andmicrocephaly, with or without other
developmental abnormalities [16]. A classic MPD is Meier-Gorlin syndrome (MGORS; MIM
224690), which is characterised by a triad of phenotypes: primordial dwarfism, microtia
(small ears), and patellar aplasia/hypoplasia (absence or hypomorphic patellae) [17,18]. Intellect
is usually preserved, and additional facial abnormalities can include microstomia (small mouth),
micrognathia (underdevelopment of the lower jaw), full lips, and a narrow nose with a high
nasal bridge; mammary hypoplasia, abnormal genitalia (cryptorchidism and hypoplastic labia
minora/majora), and pulmonary emphysema are also common [19] (Table 1).
In 2011, three seminal articles described the molecular genetics of MGORS and identified biallelic
hypomorphic mutations in components of the PRE-RC, including ORC1-ORC4-ORC6-CDC6
and CDT1 [20–22]. Subsequently, a dominant gain-of-function mutation in GMMN (GEMININ)
and hypomorphic mutations in MCM5 have been identified in patients affected by MGORS, fur-
ther corroborating the unique genetic connection between the replication licensing system and
this syndrome [23,24] (Table 1). Finally, an association of MGORS and craniosynostosis (prema-
turely closed cranial sutures) has been described in patients with biallelic loss of function muta-
tions of the PRE-IC factor CDC45 [25] (Table 1).
Seckel Syndrome and Other MPDs
Themost well-knownMPD is Seckel syndrome (SS), which takes its name from the paediatrician,
Helmut Seckel, who first described a group of patients affected by intra-/extrauterine growth re-
striction with severe microcephaly and mental retardation in association with a ‘bird-headed’ face
due to a combination of receding forehead and chin with a large and beaked nose [26]. Several
genes have been reported to be mutated in classical nonosteodysplastic SS (MIM 210600),
which is characterised by severe microcephaly and mental retardation in the absence of specific
osteodysplastic features. Seminal work by O’Driscoll et al. identified biallelic hypomorphic
mutations in ATR in patients with SS, linking SS, for the first time, to DNA replication and theTrends in Genetics, Month 2020, Vol. xx, No. xx 5
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Figure 3. The Intra-S-Phase Checkpoint. Schematic representation of the intra-S-phase checkpoint and its functions in the control of origin activation (A) and
replication fork stability (B) [86]. Discontinuous DNA replication at leading or lagging strands generates extended regions of single-stranded DNA (ssDNA), rapidly
covered by replication protein A (RPA). Accumulation of RPA at the replication fork promotes the independent recruitment of ATRIP, in concert with ATR, and ETAA1
[102–105]. The presence of a double-stranded DNA–ssDNA junction with a 5′–3′ free end allows RAD17-RFC2–5–dependent loading of the 9-1-1 complex, a
(Figure legend continued at the bottom of the next page.)
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OPEN ACCESSintra-S-phase checkpoint [27] (Table 1, Figure 3 and Box 3). Subsequent loss-of-function mu-
tations in the ATR-binding protein ATRIP [28] (Table 1) further connected activation of the ATR
pathway to the SS phenotype.
More recently, whole-exome sequencing (WES) studies have expanded the repertoire of
single gene mutations causing MPD. These include components of the replication machinery
and DNA repair factors, such as DNA2 and RBBP8/CTIP, and newly identified factors required
for replication fork stability, such as TRAIP (TRAF-interacting protein) andDONSON (downstream
neighbour of son) [29–33] (Table 1). Intriguingly, hypomorphic mutations of DONSON result in
a spectrum of different phenotypic presentations. In addition to microcephaly, short stature,
and limb abnormalities (MSSL) (MIM 617604), an RNA-sequencing approach led to the discovery
of aberrant splicing in DONSON in patients with microcephaly-micromelia syndrome (MMS)
(MIM 251230), a condition presenting with intrauterine growth restriction, severe microcephaly,
craniofacial dysmorphisms, and limb malformations, usually lethal in the perinatal period [34,35]
(Table 1). Last, mutations in DONSON have been identified in patients previously diagnosed
with classic MGORS, further expanding the breadth of phenotypes related to partial loss of
function of DONSON [36].
Mutation of Factors Required for Replication Origin Activation and/or DNA Synthesis at the
Replisome
In addition to ‘classic’ MPD, defective growth and skeletal abnormalities are characteristics of
several single-gene conditions involving components of the PRE-IC and/or replisome, in asso-
ciation or not with immune and endocrine system abnormalities. The PRE-IC component
RECQL4 is mutated in three partially overlapping genetic conditions: Rothmund-Thomson syn-
drome (RTS), RAPADILINO syndrome, and Baller-Gerold syndrome. RTS (MIM 268400) fea-
tures a characteristic and diagnostic facial rash known as poikiloderma, and a series of
heterogeneous manifestations, which include reduced intra- and extrauterine growth, sparse
hair, eyelashes, and/or eyebrows, juvenile cataracts and skeletal abnormalities, including radial
ray defects, absent or hypoplastic thumbs, hypoplasia/absence patella (similar to MGORS), syn-
dactyly, and osteoporosis [37]. RTS also presents with heightened predisposition to cancer, par-
ticularly osteosarcoma (childhood) and spinocellular carcinoma (adult) [37] (Table 1).
In 1999, homozygous or compound heterozygous mutations in RECQL4 were described in a
group of patients with RTS [38]. Hypomorphic mutations in RECQL4 have also been described
in RAPADILINO (Radial hypoplasia, Patella hypoplasia and cleft or Arched palate, Diarrhoea
and dislocated joints, Little size and limb malformation, slender Nose and nOrmal intelligence)
(MIM 266280) [39] (Table 1) and Baller-Gerold syndrome (MIM 268400), characterised by coronal
craniosynostosis, leading to abnormal skull shape, and radial aplasia [40] (Table 1).heterotrimeric, proliferating cell nuclear antigen (PCNA)-like complex composed of RAD9-HUS1-RAD1 [86]. The 9-1-1 complex promotes the stable recruitment of
TOPBP1, which is required for ATR activation [106]. Once activated, ATR phosphorylates and activates its downstream effector kinase CHK1, leading to the full
activation of the intra-S-phase response [86]. (A) Control of origin activation by the intra-S-phase checkpoint. CHK1 phosphorylates cell division cycle 25 (CDC25)
phosphatases such as CDC25A, promoting its proteasomal degradation, thus indirectly affecting CDK-CYCLIN activation, which is required for formation of the pre-
initiation complex (PRE-IC) [86]. In addition to this, CHK1 directly interacts with and phosphorylates TopBP1-interacting checkpoint and replication regulator (TICRR)/
TRESLIN, whereas ATR can directly block origin activation by phosphorylating the histone methyltransferase mixed-lineage leukaemia (MLL) and promoting H3K4
methylation and blocking of CDC45 recruitment [107,108]. (B) Control of replication fork stability and repair by the intra-S-phase checkpoint. ATR phosphorylates
several components of the replisome and can directly or indirectly affect their function. Among them, ATR phosphorylates the replication fork reversal factor
SMARCAL1 to prevent abnormal replication fork intermediate transactions and processing by the SLX4 nuclease [109]. In addition to this, ATR directly phosphorylates
components of the Fanconi anaemia pathway, RPA, MCMs (mini-chromosome maintenance), and several helicases and nucleases involved in replication fork
remodelling [86].
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Table 1. Molecular Genetics of Human Inherited Syndromes Caused by Mutations of Replisome Genes
Gene mutation Step of DNA replication MIM number link Syndrome/clinical features Refs
ORC1 PRE-RC 224690 MGORS 1 (short stature, microtia, and patellae
hypoplasia/aplasia)
[20,21]
ORC4 PRE-RC 613800 MGORS 2 [20,22]
ORC6 PRE-RC 613803 MGORS 3 [20]
CDC6 PRE-RC 613805 MGORS 5 [20]
CDT1 PRE-RC 613804 MGORS 4 [20]
MCM5 PRE-RC, PRE-IC, and replisome 617564 MGORS 8 [24]
GMNN (GEMININ) PRE-RC (inhibitor) 616835 MGORS 6 [23]
CDC45 PRE-IC and replisome 617063 MGORS 7 (Meier-Gorlin syndrome and/or craniosynostosis) [25]
MCM4 PRE-RC, PRE-IC, and replisome 609981 ID 54 (immunodeficiency 54)
Growth restriction, adrenal insufficiency and NK cell
deficiency
[42,43]
RECQL4 PRE-IC and
DNA repair
268400
218600
266280
• Rothmund-Thomson syndrome
• Baller-Gerold syndrome
• RAPADILINO syndrome
[37]
[40]
[39]
GINS1 PRE-IC and replisome 617827 ID 55 (immunodeficiency 55): growth restriction, neutropenia,
NK cell deficiency
[41]
POLE1 PRE-IC and replisome 615139
618336
FILS syndrome
IMAGe syndrome
[45]
[46]
POLE2 PRE-IC and replisome Growth restriction and immunodeficiency [49]
MCM10 Origin activation NK cell deficiency [44]
POLA1 Replisome 301220
301030
• XLPDR (X-linked pigmentary disorder, reticulate, with
systemic manifestations)
• Van Esch-O’Driscoll syndrome
[50]
[52]
POLD1 Replisome 615381 • MPDL (mandibular hypoplasia, deafness, progeroid
features, and lipodystrophy) syndrome
• Growth restriction and immunodeficiency
[53]
[55]
POLD2 Replisome Growth restriction and immunodeficiency [55]
PCNA Replisome and DNA repair 615919 Growth restriction, hearing loss, neurodegeneration,
premature ageing, telangiectasia, and photosensitivity
[56]
DNA2 Replisome and DNA repair 615807 MPD [29,30]
ATR Intra-S-phase checkpoint 210600 Seckel syndrome [27]
ATRIP Intra-S-phase checkpoint Seckel syndrome [28]
DONSON Replisome 617604
251230
• MSSL (microcephaly, short stature, and limb abnormalities)
• MMS (microcephaly-micromelia syndrome)
• MGORS
[33,35]
[34]
[36]
TRAIP Replisome and DNA repair 616777 MPD [32]
RBBP8/CTIP Replisome and DNA repair 606744
251255
• Seckel syndrome
• Jawad syndrome
[31]
[31]
Trends in GeneticsIntriguingly, mutation of factors required for initiation of DNA replication frequently feature growth
restriction and immunodeficiencies. In 2017, Cottineau et al. reported compound heterozygous
hypomorphic mutations in GINS1 (PSF1), a component of the GINS1–4 complex, in a group of
patients affected by intra- and extrauterine growth restriction with neutropenia and natural killer
(NK) cell deficiency (immunodeficiency 55 [IMD55]; MIM 617827) [41] (Table 1). Other features in-
clude mild facial dysmorphism, signs of autoimmunity, and tumour predisposition. Interestingly,
this phenotype closely resembles patients with MCM4 truncating mutations associated with
selective NK cell deficiency, reduced growth, and primal adrenal failure, also described as8 Trends in Genetics, Month 2020, Vol. xx, No. xx
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a patient with selective NK cell deficiency and increased susceptibility to cytomegalovirus infec-
tion caused by compound heterozygous mutations in MCM10 [44]. Thus, a group of genetic
diseases affecting different steps of CMG formation and activation perturbs, in a specific manner,
NK cell maturation.
Hypomorphicmutations of the catalytic subunit of POLε, POLE1, were initially described in a large
consanguineous family affected by FILS syndrome (facial dysmorphism, immunodeficiency,
livedo, and short stature) [45] (Table 1). Facial abnormalities include malar hypoplasia and high
forehead with occasional signs of bone dysplasia. Patients also present with recurrent upper
and lower respiratory tract infections due to B- and T-cell immunodeficiency. More recently, com-
pound heterozygous mutations in POLE1 have been identified by WES in multiple patients af-
fected by IMAGe syndrome (intrauterine growth restriction, metaphyseal dysplasia, adrenal
hypoplasia, and genital anomalies in males) associated with variable immunodeficiency [46]
(Table 1). IMAGe syndrome (MIM 614732) was initially described by Vilain et al. in cases of growth
retardation associated with severe adrenal insufficiency [47]. Additional features include mild
dysmorphia, bilateral cryptorchidism, a small penis, and hypogonadotropic hypogonadism. Het-
erozygous missense mutations in the PCNA binding domain of the CDK inhibitor p57 (CDKN1C)
have been lately identified in individuals with IMAGe syndrome [48]. Distinct from classical IMAGe
syndrome, mutations of POLE1 are associated with immunological dysfunction in addition to facial
abnormalities comprising micrognathia, crowded dentition, long thin nose, short wide neck, and
small, low-set, posteriorly rotated ears [46]. Osteopenia and developmental dysplasia of the hip
(DDH) were also frequently observed together with café-au-lait patches. Two patients also devel-
oped lymphomas suggesting a specific lymphoma predisposition [46]. Intriguingly, severe immu-
nodeficiency with facial dysmorphia and autoimmunity has also been associated with a
homozygous splice-site mutation in POLE2, the second major subunit of POLε, [49]. A severe
B-cell differentiation defect in this condition led to an absence of circulating B cells and agamma-
globulinemia with T-cell lymphopenia and neutropenia. Early-onset diabetes mellitus and hypothy-
roidism also suggest a significant autoimmune component [49].
A recurrent mutation in POLA1, codifying for the p180 catalytic subunit of POLα, was initially
reported in the X-linked reticulate pigmentary disorder (XLPDR; MIM 301220), a primaryBox 3. The Intra-S-Phase Checkpoint
Replication origin activation and replisome progression are intimately connected during S phase. These events are fine-
tuned both locally and over a distance to permit temporal activation of replication origins and to avoid exhaustion of dNTPs
and replication factors. The intra-S-phase checkpoint has a particularly important role in this process by modulating origin
usage and replication fork progression under both unchallenged and challenged conditions [86] (Figure 3). At the centre of
this evolutionarily conserved pathway are the essential kinases ATR (ataxia-telangiectasia and Rad3-related; Mec1 in
budding yeast) and its downstream effector CHK1 (checkpoint kinase 1; Rad53 in budding yeast). The trigger for ATR
activation is the accumulation of RPA-coated ssDNA at the replication fork, a condition typically induced by uncoupling
of dsDNA unwinding by the CMG helicase and DNA synthesis by processive DNA polymerases. RPA is recognised and
bound by ATRIP (ATR-interacting protein), an ATR-binding protein, which promotes ATR loading at stalled replication
forks [102,103]. ATR activation also requires TOPBP1, which is recruited at 5′-ended ssDNA–dsDNA junctions by the
RAD9-RAD1-HUS1 (9-1-1) complex in a RAD17-RFC2/5-dependent manner [86,106] (Figure 3). More recently, an
ATR-activating protein, Ewing tumour-associated antigen 1 (ETAA1), has been identified and shown to directly bind
RPA at stalled replication forks to promote ATR activation via a parallel pathway [104,105] (Figure 3). Once activated,
ATR phosphorylates and activates, in a CLASPIN- and TIM/TIPIN-dependent manner, its downstream effector kinase
CHK1 to promote cell cycle arrest, inhibition of origin firing, and stabilisation of replication forks to facilitate their repair
and restart [86]. The first task is achieved via CHK1-dependent phosphorylation and inhibition of CDC25 phosphatases
CDC25A, CDC25B, and CDC25C, which are required for CDK2 and CDK1 activity and progression throughout the cell
cycle [86]. More recently, Saldivar et al. have also shown that ATR is activated during DNA replication via ETAA1 to monitor
S-phase progression and prevent a CDK1-dependent FOXM1 switch that transactivates the mitotic gene network [126].
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In addition to unique facial features (frontally upswept hair and flared eyebrows), hypohidrosis,
and hyperpigmentation, multiorgan inflammation involving the eyes, the intestine, and the urinary
tract are themain features of this syndrome. Patients with XLPDR also experience recurrent infec-
tions, predominantly in the respiratory tract, resulting in early-onset bronchiectasis and respira-
tory failure [50]. Interestingly, patients with XLPDR also exhibit reduced NK cell numbers,
particularly differentiated (CD3–CD56dim) cells, reminiscent of the previously described MCM4
mutation [51]. In addition to XLPDR, Van Esch et al. reported five unrelated families with
hypomorphic POLA1 mutations associated with syndromic X-linked growth restriction and
microcephaly, intellectual disabilities, hypogonadism, and variable congenital abnormalities
(MIM 301030) [52], more closely resembling syndromes caused by dysfunctional DNA replication
initiation.
Mutations of components of the POLδ complex are associated with multiple syndromic
conditions. A recurring heterozygous single-codon deletion in POLD1 affecting the polymerase
site causes the autosomal dominant and multisystem disorder mandibular hypoplasia, with
deafness, progeroid features, and Lipodystrophy (MDPL; MIM 615381) [53]. Facial features
include a beaked nose, prominent eyes, crowded teeth, small mouth and uvula, and long
eyelashes, and they are often associated with hypogonadism and cryptorchidism in males
and metabolic anomalies such as insulin resistance. Radiologic skeletal abnormalities are
also present in some individuals. A mutation in POLD1 has also been described in patients
with atypical Werner syndrome in the absence of MDPL signs but with reduced growth [54].
More recently, mutations in both POLD1 and POLD2 have been implicated in a syndromic
growth restriction and immunodeficiency characterised by T- and B-cell reductions with NK
deficiency, closely resembling POLε hypomorphic patients [55]. Finally, a homozygous
missense mutation in PCNA causing a S228I substitution (MIM 615919) was identified in four
patients with a syndromic growth restriction associated with neurodegeneration, hearing
loss, premature ageing, telangiectasia, and photosensitivity. Both clinical presentation and
dissection of the molecular pathogenesis suggest that this condition is more likely to reflect a
DNA repair defect [56].
Mutation of Replisome-Associated Factors Required for DNA Repair and Sister Chromatin
Cohesion
DNA replication is tightly linked to sister chromatin cohesion and DNA repair [1]. As such, a
series of genetic syndromes described as DNA repair disorders are associated with defective
S-phase progression and abnormal processing of replication intermediates at stalled replication
forks. The most prominent examples are the RECQL helicase syndromes Bloom syndrome
(BLM) and Werner syndrome (WRN), Fanconi anaemia, and Schimke immune-osseous dysplasia
(SIOD) disorder [57–59]. Importantly, core features of these conditions comprise reduced
growth and developmental abnormalities in association with haematological/immunological
dysfunctions.
In addition to DNA repair disorders, compound heterozygous loss-of-function mutations of the
E3 SUMO ligase NSMCE2 (also known as MMS21), a member of the structural maintenance of
chromosomes 5–6 (SMC5–6) complex, have been reported in a primordial dwarfism combined
with severe insulin resistance and gonadal failure in association with signs of replication stress
(MIM 617253) [60]. Interestingly, homozygous or compound heterozygous mutations of another
component of the SMC5–6 complex, NSMCE3, were subsequently discovered in a different
chromosomal instability syndrome associated with severe T- and B-cell immunodeficiency
(MIM 608243) [61]. Finally, a group of autosomal recessive microcephalic disorders have been10 Trends in Genetics, Month 2020, Vol. xx, No. xx
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decatenation failure at mitosis and chromosome mis-segregation [62].
Pathogenesis of Genetic Diseases Caused by Mutation of Components of the Replisome
Human genetic disorders caused bymutation in components of the replicationmachinery share a
group of recurrent clinical manifestations, with reduced intra- and extrauterine growth being the
central theme. Hence, defective development during the embryonal stage, driven by replication
stress, represents the unifying feature.
Impaired licensing of Replication Origins (MGORS)
A paradigmatic example is MGORS, whose molecular genetics is tightly linked to the licens-
ing machinery and MCM2–7 loading at replication origins. Initial studies in patient-derived cell
lines and zebrafish connected hypomorphic mutations of PRE-RC components to reduced
chromatin loading of MCMs, slower progression through S phase, and reduced growth in
zebrafish [21] (Figure 4). Several MCM hypomorphic mice have been generated, which ex-
hibit defective development through embryonic stages and strain-dependent tumour predis-
position, a feature not classically associated with MGORS [63,64]. Mcm4Chaos3, a
hypomorphic allele of MCM4, has been associated with mammary adenocarcinomas in
the C3H genetic background and a wider spectrum of cancers in outbred strains [63,65].
Similarly, an Mcm2 hypomorphic mouse model showed a strain-specific predisposition to
thymic lymphoblastic lymphoma [66]. Studies using mouse cells hypomorphic for MCMs
have led to insights into the regulation and developmental role of dormant origins. Mouse
embryonic fibroblasts (MEFs) homozygous for Mcm4Chaos3 or an Mcm2 hypomorphic
allele fail to activate dormant origins and show signs of replication fork asymmetry and
chromosomal instability [65,66]. Genetic analysis of lymphomas from Mcm2 hypomorphic
mice showed the accumulation of atypical small (less than 0.5 kb) deletions in these tu-
mours, suggesting recombination between nearby stalled replication forks as the pathoge-
netic mechanism [67]. Organismal, developmental, and tissue-specific dynamics of loading
and activation of replication origins are likely to play a fundamental role in the phenotypic
expression of this condition, as also inferred from studies in embryonic stem cells and
neuroprogenitors [64,68].
Origin licensing is subjected to sophisticated control mechanisms. In vertebrates, a cell cycle–
regulated factor, GEMININ, keeps CDT1 under control during the S and G2 phases of the cell
cycle [69,70] (Figure 1). GEMININ is normally degraded during mitosis and G1 by anaphase-
promoting complex (APC)-mediated ubiquitination and proteolysis, which is dependent on a clas-
sical destruction box (D-box) located in its N-terminal domain [69]. Although MGORS generally
presents with an autosomal recessive pattern of inheritance due to biallelic hypomorphic muta-
tions of ORC1-ORC4-ORC6-CDC6-CDT1 and MCM5, heterozygous de novo mutations in the
5′ coding region of GEMININ were also recently reported [23]. Strikingly, these genetic
alterations result in the expression of GEMININ protein products specifically lacking the
N-terminal D-box, which confers increased stability throughout the cell cycle and insufficient
origin licensing [23] (Figure 4).
Partial loss of function mutations of CDC45 have also been associated with cases of MGORS
and/or craniosynostosis [25]. In budding yeast, Cdc45 and Sld3/Treslin are recruited to DNA
replication origins in a DDK-dependent but CDK-independent manner during the G1 phase of
cell cycle [1,71], acting as a ‘second’ licensing step of DNA replication origins. The absence of
CDK-dependent commitment to origin activation, a ‘point of no return,’ might thus help explain
the association of CDC45 mutations with MGORS. The targeting of specific replication originsTrends in Genetics, Month 2020, Vol. xx, No. xx 11
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might also play a role.
Reduced Replication Origin Activation and/or DNA Synthesis at the Replisome
Replication genetic diseases affecting the CDK-dependent step of origin activation share
similar phenotypes (Figure 4). Examples are the recently identified mutations of GINS1,
MCM4, and POLE1 in immunodeficiency 55 and 54 and IMAGe syndrome [41–43,46]. Classic
IMAGe syndrome is caused by mutations of CDKN1C, which codifies for the p57 CDK inhibitor
[48]. Mutations of p57 in patients with IMAGe syndrome occur within its PCNA-interacting
protein box (PIP-box) domain and prevent PCNA binding and proteasomal degradation
[72,73]. Hence, increased p57 stability during S phase and deregulated CDK activity might
perturb origin activation. An intriguing pathogenetic case is constituted by mutations of
MCM4, reported in patients with NK cell deficiency, growth restriction, and adrenal insuffi-
ciency [42,43]. Identified cases presented with an MCM4 splice-site mutation and generation
of two N-terminal truncated versions of MCM4 lacking 50 or 74 amino acids (aa), respectively
[42,43]. Importantly, this truncation does not affect formation of the MCM2–7 complex or
MCMs levels on chromatin, differing from a PRE-RC assembly defect and Mcm4chaos mutant
mouse cells [42]. In budding yeast, the N-terminal domain of MCM4 is targeted by several ki-
nases, such as CDK, DDK, and Mec1/ATR, to control initiation of DNA replication and coordi-
nate the checkpoint response. Hence, aa 74–178 of MCM4 contain an essential inhibitory
domain released by DDK phosphorylation, a key priming event for the formation and activation
of the CMG. Conversely, the proximal N-terminal residues contain several CDK target sites,
which are important for activation of DNA replication origins [74]. Accordingly, Sheu et al.
have shown that a MCM4 yeast strain lacking the essential CDK targets exhibits reduced origin
activation and a compensatory increase in fork speed [75].
Although humanised mouse models of MCM4, GINS1, and POLE1 mutations have not been
reported, Bellelli et al. recently characterised a mouse model lacking the POLE4 subunit of
POLε, which presented with reduced growth, craniofacial abnormalities, skeletal dysplasia,
and diminished T and B cells, closely resembling features of IMAGe syndrome [76]. Strikingly,
they also observed a slight but significant predisposition to B- and T-cell lymphomas, similar
to that reported by Logan et al. in patients with POLE1 mutations [46]. Pole4-knockout
(Pole4-KO) mouse cells exhibit instability of the POLε complex and reduced origin activation.
The striking similarities with patients with POLE1 mutations suggest that the Pole4-KO miceFigure 4. (A) Reduced licensing of DNA replication origins in Meier-Gorlin syndrome (MGORS). Hypomorphic mutations o
origin recognition complex 1–4–6 (ORC1-4-6), cell division cycle 6 (CDC6), Cdc10-dependent transcript 1 (CDT1), or mini-
chromosome maintenance 5 (MCM5) impair chromatin loading of inactive MCM2–7 double hexamers and cause
autosomal recessive MGORS [20–22,24]. De novo mutations of GEMININ prevent interaction of CDT1 with MCM2–7 and
reduce MCMs chromatin loading, causing autosomal dominant MGORS [23]. (B) Reduced activation of DNA replication
origins or dysfunctional initiation of DNA replication cause a spectrum of diseases with reduced growth and/o
immunodeficiency. Mutations of MCM10 affect CMG activation, whereas mutations of Go-Ichi-Ni-San 1 (GINS1) lead to
GINS1–4 complex instability and reduced CMG assembly [41,44]. Similarly, hypomorphic mutations of POLE1/POLE2
lead to reduced levels of POLε, preventing stable CMG formation [45,46,49]. MCM4 N-terminal truncations lead to loss o
CDK-mediated phosphorylation of MCM4, affecting origin activation [42,43]. Finally, hypomorphic mutations in POLA1 and
POLD1/POLD2 cause reduced initiation of DNA synthesis [52,55]. (C) Mutations of components of the intra-S-phase
checkpoint or factors required for replication fork stability cause microcephalic primordial dwarfism (MPD). Hypomorphic
mutations of ATR and ATRIP cause reduced levels of the ATR/ATRIP complex and cause Seckel syndrome (SS) [27,28]
Hypomorphic mutations of RBBP8/CTIP and DNA2 impair protection and/or processing of replication intermediates and
impact the ATR signalling causing SS/MPD [29–31]. Similarly, hypomorphic mutations of TRAIP affect the processing o
replication intermediates at stalled replication forks and cause MPD [32]. Finally, hypomorphic mutations of DONSON
cause a spectrum of MPDs by impairing replication fork stability and/or the ATR-dependent checkpoint [33–36].
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mouse model presented with reduced intrauterine growth and lethality in a C57BL/6 back-
ground, closely mimicking Pole4-KO mice [77]. Intriguingly, Siamishi et al. also reported the
generation of a Pole3 mouse model lacking the acidic C-terminal domain of POLE3 that was
previously shown to support POLE3–POLE4 binding to histones H3–H4 [77,78]. Although
this mouse model exhibited no major phenotypic abnormalities, suggesting compensatory
mechanisms, the gradual increased substitution of the negatively charged residues in the C-
terminus of POLE3 with positive ones led to the development of an increasingly severe B-
and T-cell deficiency [77]. This observation suggests that loss of interactions with histones
and/or other factors during DNA replication might impair differentiation of lymphocyte precur-
sors, likely through an epigenetic mechanism [79].
Mutations of the POLα subunit POLA1 have been described in patients with reduced growth,
immunodeficiency, and hypogonadism [52]. Characterisation of patient-derived cells showed
increased fork asymmetry and enhanced interorigin distance, suggestive of dysfunctional
initiation of DNA replication, resembling an insufficiency of initiation factors [52] (Figure 4).
Mechanistically, POLα is strictly required for the synthesis of RNA-DNA primers extended by
the processive DNA polymerases, thus explaining the functional defect in initiation of DNA
replication (Figure 4).
Biallelic mutations of POLD1 and POLD2 have also been identified in patients with reduced
stature, T- and B-cell lymphopenia, and NK cell deficiency, resembling POLE1 mutations
in IMAGe syndrome [55]. Mutations in both POLD1 and POLD2 significantly reduced ex-
pression of POLδ complex components in patient-derived cells, suggesting a POLδ
hypomorphic condition [55]. Analysis of replication dynamics in patient-derived cells
showed a combination of reduced origin activation and increased fork speed, suggestive
of dysfunctional replication initiation, but not a replication fork progression defect [55]. In
budding yeast, POLδ is required for initiation of leading strand DNA replication and the
establishment of two functional replisomes at replication origins [80,81]. Despite not
being physically tethered to the CMG helicase, single-molecule analysis recently suggested
that POLδ is stable at replication forks, pointing to a mechanism of continuous recycling
[82]. Thus, although reduced levels of POLδ might limit ‘functional’ activation of replication
origins, once POLδ is engaged at a replication fork, it might remain associated and promote
extensive DNA synthesis.
Defective Intra-S-Phase Checkpoint and Replication Fork Stability (SS and Other Cases of MPD)
The other paradigmatic genetic condition affecting replication fork dynamics is SS. Important
insights into the pathogenesis of this condition initially came from the development of a
humanised Atr hypomorphic mouse. While presenting with phenotypic alterations remarkably
similar to those of human patients, this model provided evidence for in utero replicative stress
as a driving force of adult phenotypic alterations [83]. Atr Seckel mouse cells and patient-derived
fibroblasts exhibit reduced fork extension rates and interorigin distance suggestive of disrupted
control of replication origin activation and fork extension/stability by the intra-S-phase checkpoint
[84–86] (Box 4). A combination of altered replication origin activation and replication fork instability
likely drive permanent fork stalling, abnormal replication fork processing, and irreversible DNA
damage.
ATR is indeed required for the control of replication origin activation under unperturbed con-
ditions and is normally activated during S phase [86]. While lagging strand DNA synthesis
has been suggested to promote ATR activation during normal DNA replication [87], recent14 Trends in Genetics, Month 2020, Vol. xx, No. xx
Box 4. Control of Origin Activation and Replication Fork Stability by the Intra-S-Phase Checkpoint
Multiple mechanisms are responsible for the inhibition of origin activation mediated by the intra-S-phase checkpoint.
Importantly, the ATR–CHK1 axis regulates origin firing in unperturbed conditions, because inhibition of ATR and CHK1
induces increased origin firing and reduced interorigin distance in the absence of replication stress, suggesting a global
deregulation of origin activation both locally and at distance [109,127]. An important role in this context is exerted by the
inhibitory phosphorylation and degradation of CDC25A mediated by CHK1, which reduces cyclin A-CDK2 activity, thus
preventing origin activation [86] (Figure 3). In addition to this, several other mechanisms have been proposed to prevent
formation of the PRE-IC upon ATR activation. In budding yeast, the essential targets of Rad53 inhibitory activity reside
in Sld3 (TICRR/TRESLIN) and Dbf4 (subunit of the CDC7-DBF4 kinase complex) [128,129]. In mammalian cells, the
situation is more complex; CHK1 directly interacts with and phosphorylates TICRR/TRESLIN, whereas ATR can also
phosphorylate the histone methyltransferase mixed-lineage leukaemia (MLL) to promote H3K4 methylation and inhibit
CDC45 chromatin loading at replication origins [107,108].
Another essential activity of the intra-S-phase checkpoint is the maintenance of replication fork stability. Although recent
studies in budding yeast and mammalian cells have shown that replisome stability is independent of Mec1/ATR activity,
loss of ATR kinase activity is associated with an inability to rescue fork stalling and resume DNA replication [2,130].
The mechanism behind this phenomenon is still incompletely characterised, but multiple ATR-dependent activities likely
cooperate to remodel and stabilise stalled replication fork intermediates to prevent their abnormal processing by
nucleases, leading to replication fork collapse [86]. For instance, ATR phosphorylates the fork remodelling enzyme
SMARCAL1 to prevent SLX4-mediated cleavage of replication forks leading to DSB formation [109]. ATR also directly
phosphorylates MCMs and Fanconi anaemia proteins to regulate replisome progression and repair as well as helicases
of the RECQ family, such as BLM andWRN, which are involved in the metabolism of replication intermediates [86]. Finally,
ATR has been shown to directly promote fork slowing and reversal to prevent excessive processing of replication fork
stalling events [131].
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of early replication origins, to promote increased deoxynucleoside triphosphate (dNTP)
synthesis and sustain genome-wide DNA replication [88]. Multiple lines of evidence suggest
that defective dNTP metabolism might play a role in the pathogenesis of replication stress
induced by ATR hypomorphic mutations. First, nucleoside supplementation can partially
rescue proliferation rates and replication stress in Atr hypomorphic MEFs [85]. Second, in
a mouse model, increased dosage of Rrm2, the gene codifying for the limiting subunit of
ribonucleotide reductase, can prolong survival of Atr Seckel mice and reduce the burden
of symptoms [85].
While hypomorphic mutations of ATRIP directly affect the levels of ATR and result in an ATR
hypomorphic condition [28], the molecular mechanisms responsible for the development of
severe cases of SS/MPD in patients with other genetic alterations is more complex. SS/
MPD causal mutations in RBBP8/CTIP lead to the production of an abnormal C-terminal
truncated product compromising MRN (MRE11-RAD50-NBS1) interaction and a CDK phos-
phorylation site. Importantly, this mutant protein retains its dimerisation domain and can act
as a dominant negative reducing double-strand break (DSB) resection, RPA accumulation on
ssDNA, and consequently ATR signalling in response to DSB-inducing agents [31]. Despite
being mainly known for its role in DSB resection, CTIP is essential for early embryonic
development, suggesting an essential role during DNA replication [89]. Although CTIP-
mediated end resection might be necessary to process replication intermediates and gener-
ate ssDNA and ATR signalling during DNA replication, recent work suggested a paradoxical
role for CTIP in the protection of newly replicated strands from DNA2-dependent nucleolytic
degradation [90]. In agreement with this hypothesis, mutations of CTIP have also been iden-
tified in patients with familial breast cancer [91]. Intriguingly, Shaheen et al. also reported a
hypomorphic mutation of BRCA2, a prominent homologous recombination factor involved
in DSB repair and fork protection, in patients with MPD in the absence of pathologic involve-
ment of the bone marrow, which precluded a diagnosis of Fanconi anaemia [30]. Instability ofTrends in Genetics, Month 2020, Vol. xx, No. xx 15
Outstanding Questions
Studies in the last two decades have
unravelled the mechanistic basis and
steps of DNA replication in eukaryotes.
However, how dysfunctional DNA rep-
lication induces human genetic dis-
ease remains to be deciphered. For
instance, how are PRE-RC factors as-
sembled at replication origins in
Meier-Gorlin syndrome? Where and
how in the genome is origin activation
perturbed upon hypomorphic muta-
tion of initiation factors such as GINS1
and POLE1?
Although sharing a common set of
clinical features, such as reduced
intra- and extrauterine growth, many
human genetic diseases caused by
mutations of replisome components
are characterised by the involvement
of specific tissues or cell populations.
The reason for this phenomenon is un-
clear. For instance, why do mutations
ofMCM4 and POLE1 specifically affect
adrenal gland development? Why do
mutations of POLE1-POLE2 and
POLD1-POLD2 lead to a reduction of
T and B cells, whereas mutations of
MCM4, MCM10 and GINS1 induce a
selective NK cell deficiency? Studying
the dynamics of DNA replication and
cellular differentiation in these subpop-
ulations might help to unravel these
clinical associations.
The ATR-dependent intra-S-phase
checkpoint has a fundamental role in
coordinating origin activation and repli-
cation fork progression and stability.
Although mutation of several compo-
nents of the replication machinery
and/or intra-S-phase checkpoint
leads to MPD, the underlying molecu-
lar defect remains to be defined. More
specifically, what are the genetic le-
sions that drive defective embryonic
development and tissue homeostasis?
Where are they occurring in the
genome?
Recently, mutations of new factors
associated with the replisome, such
as TRAIP and DONSON, have been
discovered in MPD. However, the
specific function of these proteins and
how their hypomorphic mutations
induce dysfunctional DNA replication
remain to be characterised. For exam-
ple, mutations of DONSON cause a
spectrum of clinical manifestations
ranging from MGORS to MMS,
Trends in Geneticsreplication fork intermediates undergoing fork reversal might explain these phenotypic
associations.
DNA2 is a nuclease involved in the removal of 5′-flap structures during lagging strand DNA
maturation and long-path BER [14]. Biallelic hypomorphic variants in DNA2 have been
reported in patients with severe MPD [29,30]. Dna2 is also required for Mec1 activation in
budding yeast at lagging strands and during unchallenged DNA replication [87,92]. Whether
mammalian DNA2 is necessary, along with ATRIP and ETAA1, for ATR activation remains
unclear. Nevertheless, DNA2 has a prominent role in mammals in remodelling stressed
replication forks, where, in cooperation with WRN, it promotes resection of reversed forks
to generate a 5′–3′ end necessary for TOPBP1 recruitment and ATR activation [86,93].
Therefore, DNA2, in addition to its role on the lagging strand, might be required to process
replication intermediates and promote sustained activation of ATR under both challenged
and normal DNA replication.
A severe MPD syndrome is also caused by hypomorphic mutations in the essential RING E3
ubiquitin ligase, TRAIP (TRAF-interacting protein) [32]. Identified as a PCNA-interacting pro-
tein enriched at replication forks, TRAIP travels with the replisome and promotes RPA accu-
mulation and ATR activation in response to replication stress-inducing agents, including
mitomycin-C (MMC) [94]. Subsequent work conducted at the Walter laboratory identified
TRAIP as the ubiquitin ligase required for CMG unloading and activation of the Fanconi anae-
mia pathway at interstrand crosslinks (ICLs) [95]. Importantly, CMG unloading is also re-
quired for fork reversal and incision of the crosslink at ICLs [96]. This might help explain
defective RPA accumulation and ATR signalling upon TRAIP deficiency and its pathogenetic
alteration in MPD [32,94]. In addition to this, TRAIP also ubiquitylates DNA–protein
crosslinks (DPCs) to promote their proteasomal degradation and also ubiquitylates stalled
CMGs during mitosis to promote mitotic DNA synthesis (MiDAS) [97,98]. Which of these
functions, when compromised, leads to defective growth and impaired neuronal development in
MPD remains to be established.
Finally, mutation ofDONSON in MPD results in reduced protein levels and/or subcellular localisation,
pointing to an hypomorphic pathogenetic mechanism [33]. Loss of Donson is lethal in mice, which
suggests an essential role during DNA replication [34]. In accordance with this, mechanistic studies
in human cells and patient-derived cell lines established DONSON as a novel component of the
replisome, required for replication fork stability and activation of the intra-S-phase checkpoint [33].
More recently, work by Zhang et al. has provided evidence that DONSON is particularly enriched
at replisomes in early replicating domains, suggesting a specific function in challenged and unchal-
lenged conditions in euchromatin replication [99]. In summary, the aforementioned group of genetic
syndromes caused by mutations in ATR-ATRIP, DNA2, CTIP, and the newly identified TRAIP and
DONSON replisome components share a common mechanistic basis linked to defective mainte-
nance of replication fork stability and/or ATR signalling (Figure 4).
Concluding Remarks
The identification, in the last decade, of several genetic conditions caused by mutation of the
replication machinery, significantly strengthened our perception of the role of DNA replication in
genome stability, human development, and health. The progress in genetic sequencing made
availablemore accurate molecular diagnosis for both genetic counselling and the clinical manage-
ment of patient comorbidities. Furthermore, understanding of the genetic and dynamics of
these conditions provided avenues for targeted therapies, particularly in the context of neoplastic
manifestations and haematological dysfunctions. The recent extraordinary progress in gene16 Trends in Genetics, Month 2020, Vol. xx, No. xx
suggestive of multiple roles in DNA
replication and the intra-S-phase
checkpoint.
POLα and POLε are also involved in the
maintenance of epigenetic integrity
during DNA replication. Is hypomorphic
mutation of these two components of
the replisome impacting epigenetic sta-
bility during cellular proliferation and
differentiation?
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reduce the gap between molecular diagnosis and effective treatment.
Here, we review the molecular genetics of replication-linked human genetic diseases and discuss
their pathogenetic mechanisms based on the steps of DNA replication affected and the most
recent understanding of its dynamics (Figure 4). However, despite the recent advancements,
many questions remain to be addressed (see Outstanding Questions).
Mechanistically, which regions of the genome are affected by reduced loading of MCM2–7 in
MGORS, and why? Where in the genome do replication origins fail to be activated in CMG-
POLε hypomorphic conditions? Which genomic regions undergo replication fork collapse,
and how is this triggered?
There is also a need to extend the molecular studies to systems that recapitulate these genetic
conditions and the stages of embryonic development and tissue homeostasis that are affected.
Evaluating the dynamics of origin loading and activation have proved to be significantly different
in embryonic and adult stem cells, as well as in differentiated cells from different tissues.
Addressing these questions will be fundamental to explain the involvement of particular cell pop-
ulations in these diseases and the roles exerted by specific replisome components. This is partic-
ularly relevant for cell populations of the immune system, such as NK cells in MCM4, MCM10,
and GINS1 mutant patients and lymphocytes in POLE1/2 and POLD1/2 hypomorphic individ-
uals. Similarly, the specific development of adrenal insufficiency in patients with IMAGe
syndrome and MCM4 mutations remains to be explained. The exploitation of mouse models
that resemble these syndromes, such as the Atr Seckel and Pole4-KO mice, could help extend
the study of replication origin activity to an in vivo context with its tissue-specific dynamics. The
use of organoids could also provide important insights into themechanistic basis of these diseases
[100].
In addition to this, the function of recently identified replisome-associated factors remain enig-
matic or poorly defined. A paradigmatic example is DONSON, whose hypomorphic mutations
confer a spectrum of developmental disorders ranging from MGORS to MMS [33–36]. Similarly,
which of the functions recently described for the ubiquitin ligase TRAIP is responsible for the
severe MPD caused by TRAIP hypomorphic mutations? Furthermore, although termination of
DNA replication represents a relatively recent area of investigation, the consequences of its
dysfunction for human health remain unclear. Moreover, the mechanisms responsible for replica-
tion fork collapse in SS and similar disorders remains to be established. Dysfunctional protection
of newly replicated DNA has recently emerged as an important pathogenetic mechanism in both
genetic and acquired human diseases, and we speculate that it might play an important role also
in SS and MPD pathogenesis.
Finally, an area to be further explored is the mechanisms that couple DNA replication with the
maintenance of the epigenetic information [79]. Understanding if and how mutations of specific
components of the replisome, such as MCM2, POLα, and POLε impact this process remains
to be defined and might reveal new insights into the pathogenesis of replication-associated
human genetic disease.
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